Osteopathic Manipulation May Be Effective for Musculoskeletal Conditions
THURSDAY, April 14, 2022 (HealthDay News) -- Osteopathic manipulative treatment (OMT) may be effective for musculoskeletal disorders, according to a review published online April 12 in BMJ Open.
Donatella Bagagiolo, from Scuola Superiore di Osteopatia Italiana in Turin, Italy, and colleagues conducted a systematic literature review to identify randomized studies evaluating the efficacy and safety of OMT.
Based on nine systematic reviews or meta-analyses (including 55 primary trials with 3,740 participants), OMT was evaluated for a wide range of conditions, including acute and chronic nonspecific low back pain, chronic nonspecific neck pain, chronic noncancer pain, pediatric conditions, neurological conditions, and irritable bowel syndrome (IBS). Meta-analyses revealed OMT is more effective than comparators in reducing pain and improving functional status in acute/chronic nonspecific low back pain, chronic nonspecific neck pain, and chronic noncancer pain, although effect size and quality of evidence varied. Evidence was questionable for OMT efficacy for pediatric conditions, primary headache, and IBS due to a small sample size, presence of conflicting results, and high heterogeneity. Most systematic reviews reported no adverse events.
"Although not all randomized controlled trials have investigated the safety of OMT, considering that no serious adverse events have been reported, OMT can be considered safe," the authors write.
Related Posts
U.S. Monkeypox Cases Are Declining
FRIDAY, Sept. 2, 2022 (HealthDay News) -- While the number of Americans with...
Unos científicos proponen un nuevo mecanismo subyacente del Alzheimer
MIÉRCOLES, 5 de octubre de 2022 (HealthDay News) -- Hace mucho que las placas de...
Conducir borracho y drogado es más peligroso que cada sustancia por su cuenta, según un estudio
LUNES, 31 de enero de 2022 (HealthDay News) -- Los peligros de conducir borracho...
Genetic Diseases Associated With 41 Percent of Infant Deaths
THURSDAY, March 2, 2023 (HealthDay News) -- Single-locus genetic diseases are...